Patents Assigned to Astion Development A/S
  • TREATMENT OF CONNECTIVE TISSUE DISEASES OF THE SKIN
    Publication number: 20130237607
    Abstract: The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta2 adrenoceptor agonist. The invention furthermore relates to dermatological compositions without skin sensitization properties and which contain enantiomerically pure or enriched R-enantiomers of a beta2 adrenoceptor agonist.
    Type: Application
    Filed: April 22, 2013
    Publication date: September 12, 2013
    Applicant: Astion Development A/S
    Inventors: Morten Sloth WEIDNER, Hans Christian Wulf
  • Treatment of connective tissue diseases of the skin
    Patent number: 8426475
    Abstract: The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta2 adrenoceptor agonist. The invention furthermore relates to dermatological compositions without skin sensitization properties and which contain enantiomerically pure or enriched R-enantiomers of a beta2 adrenoceptor agonist.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: April 23, 2013
    Assignee: Astion Development A/S
    Inventors: Morten Sloth Weidner, Hans Christian Wulf
  • Combination of aminosugars and cysteine or cysteine derivatives
    Publication number: 20030162732
    Abstract: The present invention relates to chemical complexes consisting of cysteine or derivatives of cysteine and an aminosugar as well as pharmaceutical compositions and dietary supplements comprising such complexes. The invention further relates to the use of such compositions or complexes for the preparation of a medicament or a dietary supplement in the suppression of hypersensitivity and inflammatory reactions such as rheumatic or dermatological disorders or to a method of treating such diseases by administering such compositions and complexes.
    Type: Application
    Filed: June 28, 2002
    Publication date: August 28, 2003
    Applicant: Astion Development A/S
    Inventor: Morten Sloth Weidner